Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1999 1
2001 1
2002 1
2003 4
2005 2
2006 1
2007 3
2008 11
2009 12
2010 7
2011 1
2012 5
2013 5
2014 11
2015 5
2016 6
2017 6
2018 9
2019 5
2020 8
2021 6
2022 10
2023 2
2024 5
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Results by year

Filters applied: Free full text. Clear all
Page 1
Integrated Hepatitis C-Opioid Use Disorder Care Through Facilitated Telemedicine: A Randomized Trial.
Talal AH, Markatou M, Liu A, Perumalswami PV, Dinani AM, Tobin JN, Brown LS. Talal AH, et al. JAMA. 2024 Apr 23;331(16):1369-1378. doi: 10.1001/jama.2024.2452. JAMA. 2024. PMID: 38568601 Free PMC article. Clinical Trial.
OBJECTIVE: To compare sustained virologic responses for hepatitis C virus among persons with opioid use disorder treated through facilitated telemedicine integrated into opioid treatment programs compared with off-site hepatitis specialist referral. ...Subgroup effects wer …
OBJECTIVE: To compare sustained virologic responses for hepatitis C virus among persons with opioid use disorder treated through faci …
Clinical, Biomarker, and Research Tests Among US Government Personnel and Their Family Members Involved in Anomalous Health Incidents.
Chan L, Hallett M, Zalewski CK, Brewer CC, Zampieri C, Hoa M, Lippa SM, Fitzgibbon E, French LM, Moses AD, van der Merwe AJ, Pierpaoli C, Turtzo LC, Yonter S, Shahim P; NIH AHI Intramural Research Program Team; Moore B, Stamps L, Flynn S, Fontana J, Tata S, Lo J, Fernandez MA, Joseph AL, Matsubara J, Goldberg J, Nguyen TD, Sasson N, Lely J, Smith B, King KA, Chisholm J, Christensen J, Magone MT, Cousineau-Krieger C, Hafiz R, Nayak A, Irfanoglu O, Attaripour S, Lai C, Smith WB. Chan L, et al. JAMA. 2024 Apr 2;331(13):1109-1121. doi: 10.1001/jama.2024.2413. JAMA. 2024. PMID: 38497797 Free PMC article.
Participants with AHIs had significantly increased fatigue, depression, posttraumatic stress, imbalance, and neurobehavioral symptoms compared with the control participants. ...CONCLUSIONS AND RELEVANCE: In this exploratory study, there were no significant differences betw …
Participants with AHIs had significantly increased fatigue, depression, posttraumatic stress, imbalance, and neurobehavioral symptoms …
Anxiety and Depression Symptoms After the Dobbs Abortion Decision.
Thornburg B, Kennedy-Hendricks A, Rosen JD, Eisenberg MD. Thornburg B, et al. JAMA. 2024 Jan 23;331(4):294-301. doi: 10.1001/jama.2023.25599. JAMA. 2024. PMID: 38261045 Free PMC article.
OBJECTIVE: To estimate changes in anxiety and depression symptoms following the Dobbs decision among people residing in states with trigger laws compared with those without them. ...MAIN OUTCOMES AND MEASURES: Anxiety and depression symptoms were measured via the Pa …
OBJECTIVE: To estimate changes in anxiety and depression symptoms following the Dobbs decision among people residing in states with t …
Nurse and Social Worker Palliative Telecare Team and Quality of Life in Patients With COPD, Heart Failure, or Interstitial Lung Disease: The ADAPT Randomized Clinical Trial.
Bekelman DB, Feser W, Morgan B, Welsh CH, Parsons EC, Paden G, Baron A, Hattler B, McBryde C, Cheng A, Lange AV, Au DH. Bekelman DB, et al. JAMA. 2024 Jan 16;331(3):212-223. doi: 10.1001/jama.2023.24035. JAMA. 2024. PMID: 38227034 Free PMC article. Clinical Trial.
Secondary quality-of-life outcomes at 6 months included disease-specific health status (Clinical COPD Questionnaire; Kansas City Cardiomyopathy Questionnaire-12), depression (Patient Health Questionnaire-8) and anxiety (Generalized Anxiety Disorder-7) symptoms. ...T …
Secondary quality-of-life outcomes at 6 months included disease-specific health status (Clinical COPD Questionnaire; Kansas City Cardiomyopa …
Atrial Fibrillation Catheter Ablation vs Medical Therapy and Psychological Distress: A Randomized Clinical Trial.
Al-Kaisey AM, Parameswaran R, Bryant C, Anderson RD, Hawson J, Chieng D, Segan L, Voskoboinik A, Sugumar H, Wong GR, Finch S, Joseph SA, McLellan A, Ling LH, Morton J, Sparks P, Sanders P, Lee G, Kistler PM, Kalman JM. Al-Kaisey AM, et al. JAMA. 2023 Sep 12;330(10):925-933. doi: 10.1001/jama.2023.14685. JAMA. 2023. PMID: 37698564 Free PMC article. Clinical Trial.
MAIN OUTCOMES AND MEASURES: The primary outcome was Hospital Anxiety and Depression Scale (HADS) score at 12 months. Secondary outcomes included follow-up assessments of prevalence of severe psychological distress (HADS score >15), anxiety HADS score, depression
MAIN OUTCOMES AND MEASURES: The primary outcome was Hospital Anxiety and Depression Scale (HADS) score at 12 months. Secondary outcom …
Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.
Raison CL, Sanacora G, Woolley J, Heinzerling K, Dunlop BW, Brown RT, Kakar R, Hassman M, Trivedi RP, Robison R, Gukasyan N, Nayak SM, Hu X, O'Donnell KC, Kelmendi B, Sloshower J, Penn AD, Bradley E, Kelly DF, Mletzko T, Nicholas CR, Hutson PR, Tarpley G, Utzinger M, Lenoch K, Warchol K, Gapasin T, Davis MC, Nelson-Douthit C, Wilson S, Brown C, Linton W, Ross S, Griffiths RR. Raison CL, et al. JAMA. 2023 Sep 5;330(9):843-853. doi: 10.1001/jama.2023.14530. JAMA. 2023. PMID: 37651119 Free PMC article.
IMPORTANCE: Psilocybin shows promise as a treatment for major depressive disorder (MDD). OBJECTIVE: To evaluate the magnitude, timing, and durability of antidepressant effects and safety of a single dose of psilocybin in patients with MDD. ...MAIN OUTCOMES AND MEASU …
IMPORTANCE: Psilocybin shows promise as a treatment for major depressive disorder (MDD). OBJECTIVE: To evaluate the magnitude, …
Associations of Unintended Pregnancy With Maternal and Infant Health Outcomes: A Systematic Review and Meta-analysis.
Nelson HD, Darney BG, Ahrens K, Burgess A, Jungbauer RM, Cantor A, Atchison C, Eden KB, Goueth R, Fu R. Nelson HD, et al. JAMA. 2022 Nov 1;328(17):1714-1729. doi: 10.1001/jama.2022.19097. JAMA. 2022. PMID: 36318133 Free PMC article.
MAIN OUTCOMES AND MEASURES: Prenatal depression, postpartum depression, maternal experience of interpersonal violence, preterm birth, and infant low birth weight. ...Results were similar in sensitivity analyses based on controlling for history of depression f …
MAIN OUTCOMES AND MEASURES: Prenatal depression, postpartum depression, maternal experience of interpersonal violence, preterm …
Effect of Paroxetine or Quetiapine Combined With Oxycodone vs Oxycodone Alone on Ventilation During Hypercapnia: A Randomized Clinical Trial.
Florian J, van der Schrier R, Gershuny V, Davis MC, Wang C, Han X, Burkhart K, Prentice K, Shah A, Racz R, Patel V, Matta M, Ismaiel OA, Weaver J, Boughner R, Ford K, Rouse R, Stone M, Sanabria C, Dahan A, Strauss DG. Florian J, et al. JAMA. 2022 Oct 11;328(14):1405-1414. doi: 10.1001/jama.2022.17735. JAMA. 2022. PMID: 36219407 Free PMC article. Clinical Trial.
IMPORTANCE: Opioids can cause severe respiratory depression by suppressing feedback mechanisms that increase ventilation in response to hypercapnia. Following the addition of boxed warnings to benzodiazepine and opioid products about increased respiratory depression
IMPORTANCE: Opioids can cause severe respiratory depression by suppressing feedback mechanisms that increase ventilation in response …
Changes in Health and Quality of Life in US Skilled Nursing Facilities by COVID-19 Exposure Status in 2020.
Barnett ML, Waken RJ, Zheng J, Orav EJ, Epstein AM, Grabowski DC, Joynt Maddox KE. Barnett ML, et al. JAMA. 2022 Sep 13;328(10):941-950. doi: 10.1001/jama.2022.15071. JAMA. 2022. PMID: 36036916 Free PMC article.
In 2018-2019, across all SNFs, residents required assistance with an additional 0.89 ADLs between January and November, and lost 1.9 lb; 27.1% had worsened depressive symptoms. In 2020, residents in active COVID-19 SNFs required assistance with an additional 0.36 ADLs (95% …
In 2018-2019, across all SNFs, residents required assistance with an additional 0.89 ADLs between January and November, and lost 1.9 lb; 27. …
128 results